Skip to main content

CFAR Developmental Awardee Recognized by American Academy of Neurology (AAN)

December 17, 2021

The American Academy of Neurology recently awarded neurologist Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively-impaired people with HIV.   Click here to read the full article on UNC School of Medicine’s website.

PrEP Open House

July 5, 2018

NCATEC will be hosting “PrEP Open House: What Doctors Need to Know; What Patients Need to Ask” on Friday June 29 from 2pm to 3:30pm in the first floor auditorium of the Bioinformatics Building (130 Mason Farm Road) on the campus of UNC-Chapel Hill.  Public parking is available across the street. This training will address … Read more

Ryan White Remembered

April 26, 2018

April 8 marks the 28 year anniversary of Ryan White’s death. Before HIV transmission was well understood, factor 8, a protein important to blood clotting, was often pooled from hundreds of untested blood donations.  This exposed hemophilia patients like Ryan White to HIV; in an article for PBS Newshour, Dr. Howard Markel recalls that “virtually … Read more

Student Brings Panel of AIDS Quilt to UNC

January 31, 2018

As a freshman at UNC, Elizabeth Trefney remembers seeing a flyer publicizing a class about HIV/AIDS. The semester-long course is offered each spring by the UNC Center for AIDS Research (CFAR) and is open to all students. Past classes have focused on how the virus impacts the immune system, currently available treatments and the latest … Read more

Testing Antibodies to Prevent HIV

November 6, 2017

The journal Science published a perspective on Oct. 6, by two leading HIV investigators highlighting the next frontier of HIV prevention – broadly neutralizing antibodies or bnAbs. Antibodies to HIV can be found in 25 percent of people living with the virus who are not on treatment, wrote perspective co-author Myron Cohen, MD, associate director … Read more

Global Health: What’s in It for Us?

November 6, 2017

Satish Gopal, MD, MPH, directs the cancer program at UNC Project-Malawi. He is the only medical oncologist in Malawi, a nation of more than 18 million people. He has received two developmental and two supplemental awards through the UNC CFAR to support his research. Yet, when his daughter became sick with malaria recently, he paused … Read more

Video: CFAR Cores Present at Friday Conference

November 6, 2017

The directors of the UNC CFAR’s Biostatistics, Developmental, and Social and Behavioral Science Research Cores presented during Friday Morning Conference on Sept. 22. Watch their presentations here.

NIH Increases Funding for iTech Center

September 15, 2017

The National Institutes of Health (NIH) has awarded the UNC/Emory Center for Innovative Technology (iTech) an additional $13 million to develop interventions for youth at risk for or living with HIV. “iTech will serve as the first NIH-funded center to use technology in innovative ways to engage HIV infected or at-risk youth,” says Principal Investigator … Read more

Hudgens Co-edits Book on Quantitative Methods

September 15, 2017

Michael Hudgens, PhD, professor of biostatistics at the UNC Gillings School of Global Public Health, is co-editor of a new book, Quantitative Methods for HIV/AIDS Research, published Aug. 15 by CRC Press. The text brings together the perspectives of statisticians and mathematicians engaged in research on HIV/AIDS. “We hope that the work will inspire more … Read more

Eron Named Vice Chair of Largest NIH HIV Research Network

September 15, 2017

UNC Professor of Medicine Joseph Eron, MD, has been elected vice chair of the AIDS Clinical Trials Group (ACTG). Established by the National Institutes of Health (NIH) in 1987, the ACTG is the largest network of research sites in the world dedicated to finding a cure for HIV and the virus’s opportunistic infections. “The ACTG … Read more

Vorinostat Dosing Exposes Latent HIV

September 15, 2017

Exposing hidden HIV reservoirs so that they can be cleared is a strategy being tested in efforts to develop therapies to cure the nearly 40 million people worldwide living with HIV. Researchers at the University of North Carolina at Chapel Hill have shown that interval dosing of the drug Vorinostat reverses HIV latency and is … Read more

Connecting the Community with Research

September 15, 2017

Kareem Greene believes the once daily pill to prevent HIV has kept him virus-free on at least two occasions. It is a fact he shared candidly during an outreach event at the LGBTQ Center in Durham the last Friday in June. “I know two former partners who are living with HIV,” Greene said. “But I … Read more